Ron M. Johnson

Ron Johnson is President of Becker & Associates Consulting, Inc. (Becker Consulting).  Mr. Johnson brings more than 30 years of senior FDA leadership experience as well as 14 years of applied consulting practice assisting FDA-regulated companies with complex regulatory and compliance matters, particularly in the field of Medical Device Compliance and Quality Systems.  Through numerous senior FDA management positions at the District Office level and at the Center for Devices and Radiological Health (CDRH), and experience as a trusted advisor to industry, both as a consultant and a valued board member for pharmaceutical corporations, Mr. Johnson has developed a uniquely multi-faceted perspective on regulatory and compliance issues.

Mr. Johnson’s prominent FDA leadership positions include Director of Compliance at CDRH and Director of the Pacific Region.  In the latter position, he managed the execution of FDA’s consumer and enforcement programs in the nine western states (including Hawaii and Alaska) and the Pacific Trust Territories, including the activities of 600 administrative, inspectional, laboratory, and compliance personnel stationed in three of FDA’s largest field installations.  In addition, Mr. Johnson has played an active role in the development of FDA policies and training of personnel as Chair of FDA’s Public Affairs Field Committee, Chair of FDA’s Human Resources Field Committee, a member of FDA’s Enforcement Policy Council, and Course Leader for FDA’s Evidence Development Training Program for New Investigators and Analysts.

He has received numerous awards in recognition of his government service and leadership, including multiple FDA Commissioner Special Citations, three FDA Awards of Merit, ten “Hammer” Awards from Vice President Al Gore and the National Performance Review, a US Public Health Service Superior Service Award, and a citation for exemplary leadership in FDA by the US House of Representatives Oversight Committee.   

Mr. Johnson’s wide ranging experience and resulting intimate understanding of FDA regulatory and compliance issues from the perspective of both FDA and regulated industry enable him to develop and execute strategic, timely solutions for industry that both meet current client needs and anticipate potential future issues.